Child self-reported quality of life in pediatric intestinal failure

Melissa Wong1, Victoria C Neam2, Simon P Horslen3

  • 1University of Washington School of Medicine, Seattle, WA 98195, USA.

Insights

Children with intestinal failure (IF) report better health-related quality of life (HRQOL) than their parents perceive. However, their HRQOL remains lower than healthy peers, with longer bowel length linked to poorer outcomes.

Area of Science:

  • Pediatric gastroenterology
  • Child health outcomes
  • Quality of life research

Background:

  • Limited data exists on health-related quality of life (HRQOL) in children with intestinal failure (IF) from the child's perspective.
  • Most existing research relies on parent-reported HRQOL, potentially missing the child's unique experiences.

Purpose of the Study:

  • To investigate child self-reported HRQOL in pediatric patients with IF.
  • To compare child-reported HRQOL with parent-proxy reports and normative data.
  • To identify factors associated with HRQOL in children with IF.

Main Methods:

  • Prospective study conducted in a regional intestinal rehabilitation program (2015-2019).
  • Annual administration of the PedsQL 4.0 Generic Core Scales to children (≥5 years) with IF and their parents.
  • Analysis included age stratification, comparison with parent-proxy scores and reference populations, and linear mixed-effect models.

Main Results:

  • 140 surveys from 69 children with IF (median age 8 years).
  • Child-reported HRQOL scores increased with age and were higher than parent-proxy scores across all age groups.
  • Children with IF reported significantly lower HRQOL than healthy children and lower school/social functioning than chronically ill children.
  • Longer remnant bowel length was associated with decreased child-reported HRQOL.

Conclusions:

  • Children with IF provide a more optimistic HRQOL perspective than their parents.
  • Despite age-related improvements, child-reported HRQOL in IF remains suboptimal compared to peers.
  • The inverse relationship between bowel length and HRQOL warrants further investigation.
Abstract

Related Concept Videos

Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
326
Assessment of the Gastrointestinal System II: Health Perception Pattern01:29

Assessment of the Gastrointestinal System II: Health Perception Pattern

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
184
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
18
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
451
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
19
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
449